Q3 2012

Filed Apr 16, 2012 · 10-Q · 47 days after period end · 0001019687-12-001380

Q3 2012 · 10-Q

Revenue—

Net Income

-$1.25M

N/M vs Q3 2011

EPS, diluted—

Operating Cash Flowderived-$313,047N/M

Free Cash Flowderived$2,233,957—

Same quarter

Metric	Q3 2012	Q3 2011
Net Income	-$1.25M	-$5.65M
EPS Diluted	—	-$0.01

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Mosaic ImmunoEngineering Inc. · CIK 836564 · Engraved from SEC EDGAR